☆ 4.6 Letter

Poor outcome and prolonged persistence of SARS-CoV-2 RNA in COVID-19 patients with haematological malignancies; King's College Hospital experience

BRITISH JOURNAL OF HAEMATOLOGY (2020)

期刊

BRITISH JOURNAL OF HAEMATOLOGY

卷 190, 期 5, 页码 E279-E282

出版社

WILEY

DOI: 10.1111/bjh.16935

关键词

COVID-19; SARS-CoV-2; haematological malignancies; lymphoid malignancies; myeloid malignancies; stem cell transplantation

类别

Hematology

向作者/读者索取更多资源

Protocol

Reagent

作者

我是这篇论文的作者

点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6

评分不足

次要评分

新颖性

-

重要性

-

科学严谨性

-

评价这篇论文

推荐

Article Hematology

COVID-19 elicits an impaired antibody response against SARS-CoV-2 in patients with haematological malignancies

Francesco Passamonti, Alessandra Romano, Marco Salvini, Francesco Merli, Matteo G. Della Porta, Riccardo Bruna, Elisa Coviello, Ilaria Romano, Roberto Cairoli, Roberto Lemoli, Francesca Farina, Adriano Venditti, Alessandro Busca, Marco Ladetto, Massimo Massaia, Antonio Pinto, Luca Arcaini, Agostino Tafuri, Francesco Marchesi, Nicola Fracchiolla, Monica Bocchia, Daniele Armiento, Anna Candoni, Mauro Krampera, Mario Luppi, Valeria Cardinali, Sara Galimberti, Chiara Cattaneo, Elettra Ortu La Barbera, Roberto Mina, Francesco Lanza, Giuseppe Visani, Pellegrino Musto, Luigi Petrucci, Francesco Zaja, Paolo A. Grossi, Lorenza Bertu, Livio Pagano, Paolo Corradini

Summary: The study found a low rate of seroconversion in patients with hematological malignancies, possibly due to treatment-mediated immune dysfunction.

BRITISH JOURNAL OF HAEMATOLOGY (2021)

添加到收藏夹

Article Medicine, General & Internal

Nirmatrelvir/ritonavir in COVID-19 patients with haematological malignancies: a report from the EPICOVIDEHA registry

Jon Salmanton-Garcia, Francesco Marchesi, Maria Gomes da Silva, Francesca Farina, Julio Davila-Valls, Yavuz M. Bilgin, Andreas Glenthoj, Iker Falces-Romero, Jaap Van Doesum, Jorge Labrador, Caterina Buquicchio, Shaimaa El-Ashwah, Verena Petzer, Jens Van Praet, Martin Schoenlein, Michelina Dargenio, Gustavo-Adolfo Mendez, Stef Meers, Federico Itri, Antonio Giordano, Laszlo Imre Pinczes, Ildefonso Espigado, Zlate Stojanoski, Alberto Lopez-Garcia, Lucia Prezioso, Ozren Jaksic, Antonio Vena, Nicola S. Fracchiolla, Tomas Jose Gonzalez-Lopez, Natasa Colovic, Mario Delia, Barbora Weinbergerova, Monia Marchetti, Joyce Marques de Almeida, Olimpia Finizio, Caroline Besson, Monika M. Biernat, Toni Valkovic, Tobias Lahmer, Annarosa Cuccaro, Irati Ormazabal-Velez, Josip Batinic, Noemi Fernandez, Nick De Jonge, Carlo Tascini, Amalia N. Anastasopoulou, Remy Dulery, Maria Ilaria Del Principe, Gaetan Plantefeve, Mario Virgilio Papa, Marcio Nucci, Moraima Jimenez, Avinash Aujayeb, Jose-angel Hernandez-Rivas, Maria Merelli, Chiara Cattaneo, Ola Blennow, Anna Nordlander, Alba Cabirta, Gina Varricchio, Maria Vittoria Sacchi, Raul Cordoba, Elena Arellano, Stefanie K. Grafe, Dominik Wolf, Ziad Emarah, Emanuele Ammatuna, Ditte Stampe Hersby, Sonia Martin-Perez, Raquel Nunes Rodrigues, Laman Rahimli, Livio Pagano, Oliver A. Cartney

Summary: Nirmatrelvir/ritonavir treatment is associated with lower mortality in hematological malignancy patients. The treatment is related to the presence of extra-pulmonary symptoms and vaccination status for COVID-19, but not chronic pulmonary disease or obesity.

ECLINICALMEDICINE (2023)

添加到收藏夹

Article Hematology

Humoral response to mRNA-based COVID-19 vaccine in patients with myeloid malignancies

Akio Mori, Masahiro Onozawa, Shihori Tsukamoto, Takashi Ishio, Emi Yokoyama, Koh Izumiyama, Makoto Saito, Haruna Muraki, Masanobu Morioka, Takanori Teshima, Takeshi Kondo

Summary: This study investigates the response to COVID-19 vaccination in patients with myeloid malignancies. The findings suggest that most patients with myeloid malignancies develop an immune response to the vaccine, but leukemia patients may have lower antibody levels. This indicates that the response to the vaccine may be related to disease subtype and treatment status.

BRITISH JOURNAL OF HAEMATOLOGY (2022)

添加到收藏夹

Review Oncology

Haematological malignancies implications during the times of the COVID-19 pandemic

Eleni Papakonstantinou, Konstantina Dragoumani, Aspasia Efthimiadou, Anastasia Palaiogeorgou, Katerina Pierouli, Thanasis Mitsis, George Chrousos, Flora Bacopoulou, Dimitrios Vlachakis

Summary: The COVID-19 pandemic has worsened healthcare services for cancer patients, especially those with haematological malignancies. Clinicians are facing challenges in maintaining productivity while adhering to strict policies to prevent virus transmission. Improvements in healthcare services are crucial not only for the current pandemic but also for future management of patients in potential pandemics.

ONCOLOGY LETTERS (2021)

添加到收藏夹

Article Hematology

Breakthrough COVID-19 in vaccinated patients with hematologic malignancies: results from the EPICOVIDEHA survey

Livio Pagano, Jon Salmanton-Garcia, Francesco Marchesi, Ola Blennow, Maria Gomes da Silva, Andreas Glenthoj, Jaap van Doesum, Yavuz M. Bilgin, Alberto Lopez-Garcia, Federico Itri, Raquel Nunes Rodrigues, Barbora Weinbergerova, Francesca Farina, Giulia Dragonetti, Caroline Berg Venemyr, Jens van Praet, Ozren Jaksic, Toni Valkovic, Iker Falces-Romero, Sonia Martin-Perez, Moraima Jimenez, Julio Davila-Valls, Martin Schonlein, Emanuele Ammatuna, Stef Meers, Mario Delia, Zlate Stojanoski, Anna Nordlander, Tobias Lahmer, Laszlo Imre Pinczes, Caterina Buquicchio, Klara Piukovics, Irati Ormazabal-Velez, Nicola Fracchiolla, Michail Samarkos, Gustavo-Adolfo Mendez, Jose-Angel Hernandez-Rivas, Ildefonso Espigado, Martin Cernan, Verena Petzer, Sylvain Lamure, Roberta di Blasi, Joyce Marques de Almedia, Michelina Dargenio, Monika M. Biernat, Mariarita Sciume, Cristina de Ramon, Nick de Jonge, Josip Batinic, Avinash Aujayeb, Monia Marchetti, Guillemette Fouquet, Noemi Fernandez, Giovanni Zambrotta, Maria Vittoria Sacchi, Anna Guidetti, Fatih Demirkan, Lucia Prezioso, Zdenek Racil, Marcio Nucci, Milos Mladenovic, Raphael Lievin, Michaela Hanakova, Stefanie Grafe, Uluhan Sili, Marina Machado, Chiara Cattaneo, Tatjana Adzic-Vukicevic, Luisa Verga, Jorge Labrador, Laman Rahimli, Matteo Bonanni, Francesco Passamonti, Antonio Pagliuca, Paolo Corradini, Martin Hoenigl, Philipp Koehler, Alessandro Busca, Oliver A. Cornely

Summary: Limited data are available on breakthrough COVID-19 in patients with hematologic malignancy (HM) after anti-SARS-CoV-2 vaccination. This study found a relatively low mortality rate among patients with breakthrough COVID-19, with the Omicron variant being the predominant strain. Patients receiving monoclonal antibody treatment had a lower mortality rate.

BLOOD (2022)

添加到收藏夹

Article Hematology

Oral anti-viral therapy for early COVID-19 infection in patients with haematological malignancies: A multicentre prospective cohort

Carla Minoia, Lucia Diella, Tommasina Perrone, Giacomo Loseto, Carmen Pelligrino, Immacolata Attolico, Crescenza Pasciolla, Valentina Totaro, Maria Stella De Candia, Vito Spada, Felice Clemente, Michele Camporeale, Francesco Di Gennaro, Attilio Guarini, Pellegrino Musto, Annalisa Saracino, Davide Fiore Bavaro

Summary: High rates of lung failure have been observed in haematological patients with SARS-CoV2 infection. Early administration of monoclonal antibodies or antivirals may improve prognosis. The use of oral antivirals may have broader applications regardless of the genetic variations of the virus.

BRITISH JOURNAL OF HAEMATOLOGY (2023)

添加到收藏夹

Article Medicine, General & Internal

Fourth mRNA COVID-19 vaccination in immunocompromised patients with haematological malignancies (COBRA KAI): a cohort study

Quincy Hofsink, Sabine Haggenburg, Birgit I. Lissenberg-Witte, Annoek E. C. Broers, Jaap A. van Doesum, Rob S. van Binnendijk, Gerco den Hartog, Michel S. Bhoekhan, Nienke J. E. Haverkate, Johan van Meerloo, Judith A. Burger, Joey H. Bouhuijs, Gaby P. Smits, Dorine Wouters, Ester M. M. van Leeuwen, Hetty J. Bontkes, Neeltje A. Kootstra, Sandra Vogels-Nooijen, Nynke Rots, Josine van Beek, Mirjam H. M. Heemskerk, Kazimierz Groen, Tom van Meerten, Pim G. N. J. Mutsaers, Marit J. van Gils, Abraham Goorhuis, Caroline E. Rutten, Mette D. Hazenberg, Inger S. Nijhof, COBRA KAI Study Team

Summary: In this study, the impact of a fourth mRNA COVID-19 vaccination on antibody quantity and quality in patients with haematological malignancies was investigated. The results showed that although S1 IgG concentrations significantly improved after the fourth dose, they remained lower compared to healthy individuals after the first booster dose. The rise in neutralising antibody concentration was most prominent in patients with a recovering B cell compartment.

ECLINICALMEDICINE (2023)

添加到收藏夹

Review Biochemistry & Molecular Biology

Myeloid cells in COVID-19 microenvironment

Guohui Qin, Shasha Liu, Li Yang, Weina Yu, Yi Zhang

Summary: Variation in myeloid cell differentiation is common in tumors, inflammation, autoimmune diseases, and metabolic diseases. Single-cell sequencing reveals the differentiation trajectory of myeloid cells in COVID-19 patients. Targeting myeloid cell-derived cytokines or checkpoints is crucial in developing therapeutic strategies for severe COVID-19 patients.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)

添加到收藏夹

Review Hematology

Immunogenicity of COVID-19 vaccines in patients with hematologic malignancies: a systematic review and meta-analysis

Joanne S. K. Teh, Julien Coussement, Zoe C. F. Neoh, Tim Spelman, Smaro Lazarakis, Monica A. Slavin, Benjamin W. Teh

Summary: This study assessed the immunogenicity and safety of COVID-19 vaccines in patients with hematologic malignancies. The results showed that the seropositivity rates after 2 doses of COVID-19 vaccine were 62% to 66%, and after 1 dose were 37% to 51%. The neutralizing antibody response rates were 57% to 60%, and cellular response rates were 40% to 75%. Active treatment, ongoing or recent treatment with targeted therapies were associated with poor immune responses to COVID-19 vaccine.

BLOOD ADVANCES (2022)

添加到收藏夹

Review Immunology

Allogeneic hematopoietic stem cell transplantation in the COVID-19 era

Jonathan Bordat, Sebastien Maury, Mathieu Leclerc

Summary: Allo-HSCT recipients are highly vulnerable to COVID-19 due to immunodeficiency, and changes in clinical practice have been implemented to reduce the risk. mRNA vaccines have shown effectiveness in preventing severe forms of the disease, but Allo-HSCT recipients may have a poor response to vaccination. Challenges include adapting vaccine protection to emerging variants.

FRONTIERS IN IMMUNOLOGY (2023)

添加到收藏夹

Review Medicine, General & Internal

Covid-19 Vaccines - Immunity, Variants, Boosters

Dan H. Barouch

Summary: This article reviews the protective effects of vaccination and prior infection on severe Covid-19, and proposes future research directions.

NEW ENGLAND JOURNAL OF MEDICINE (2022)

添加到收藏夹

Article Multidisciplinary Sciences

Multi-kingdom gut microbiota analyses define COVID-19 severity and post-acute COVID-19 syndrome

Qin Liu, Qi Su, Fen Zhang, Hein M. Tun, Joyce Wing Yan Mak, Grace Chung-Yan Lui, Susanna So Shan Ng, Jessica Y. L. Ching, Amy Li, Wenqi Lu, Chenyu Liu, Chun Pan Cheung, David S. C. Hui, Paul K. S. Chan, Francis Ka Leung Chan, Siew C. Ng

Summary: By integrating clinical features and multi-omics data, the authors identified specific gut microbiome patterns associated with disease severity and development of post-acute COVID-19 syndrome. These findings highlight the potential utility of host phenotype and multi-kingdom microbiota profiling as a prognostic tool for patients with COVID-19.

NATURE COMMUNICATIONS (2022)

添加到收藏夹

Editorial Material Immunology

Transition to endemicity: Understanding COVID-19

Rustom Antia, M. Elizabeth Halloran

Summary: The article discusses the basic concepts underlying the transition from an epidemic to an endemic state, as well as the implications of this transition for COVID-19.

IMMUNITY (2021)

添加到收藏夹

Article Multidisciplinary Sciences

Spatiotemporal pattern of COVID-19 spread in Brazil

Marcia C. Castro, Sun Kim, Lorena Barberia, Ana Freitas Ribeiro, Susie Gurzenda, Karina Braga Ribeiro, Erin Abbott, Jeffrey Blossom, Beatriz Rache, Burton H. Singer

Summary: The study found that COVID-19 in Brazil is spreading rapidly across municipalities with distinct spatial and temporal patterns of clustering, trajectories, and speed. Analysis shows that inadequate policy measures have led to high transmission and mortality burdens. The current surge in cases and deaths, along with the circulation of concerning variants, highlights the need for government to strengthen prevention and control measures.

SCIENCE (2021)

添加到收藏夹

Review Public, Environmental & Occupational Health

Recent Chronology of COVID-19 Pandemic

Sazada Siddiqui, Heba Waheeb Saeed Alhamdi, Huda Ahmed Alghamdi

Summary: COVID-19 is highly contagious and has caused major disruptions around the world. Prevention is crucial through measures such as self-isolation and vaccination.

FRONTIERS IN PUBLIC HEALTH (2022)

添加到收藏夹

Article Psychology, Clinical

A randomised controlled trial of acceptance and commitment therapy for improving quality of life in people with muscle diseases

Michael Rose, Christopher D. Graham, Nicola O'Connell, Chiara Vari, Victoria Edwards, Emma Taylor, Lance M. McCracken, Aleksander Radunovic, Wojtek Rakowicz, Sam Norton, Trudie Chalder

Summary: This study aimed to investigate whether Acceptance and Commitment Therapy (ACT) could improve the quality of life in patients with chronic muscle diseases. The results showed that ACT, as an adjunct to usual care, significantly improved the quality of life and other psychological and social outcomes in these patients.

PSYCHOLOGICAL MEDICINE (2023)

添加到收藏夹

Article Rheumatology

Influence of Social Support, Financial Status, and Lifestyle on the Disparity Between Inflammation and Disability in Rheumatoid Arthritis

James M. Gwinnutt, Sam Norton, Kimme L. Hyrich, Mark Lunt, Bernard Combe, Nathalie Rincheval, Adeline Ruyssen-Witrand, Bruno Fautrel, Daniel F. McWilliams, David A. Walsh, Elena Nikiphorou, Patrick D. W. Kiely, Adam Young, Jacqueline R. Chipping, Alex MacGregor, Suzanne M. M. Verstappen

Summary: This study investigated the impact of social support, financial status, and lifestyle on the development of excess disability in rheumatoid arthritis (RA). The study found that individuals with less social support, worse financial situation, less exercise, and lower education were more likely to have excess disability. These findings were validated in two independent datasets.

ARTHRITIS CARE & RESEARCH (2023)

添加到收藏夹

Article Rheumatology

2022 EULAR recommendations for screening and prophylaxis of chronic and opportunistic infections in adults with autoimmune inflammatory rheumatic diseases

George E. Fragoulis, Elena Nikiphorou, Mrinalini Dey, Sizheng Steven Zhao, Delphine Sophie Courvoisier, Laurent Arnaud, Fabiola Atzeni, Georg M. N. Behrens, Johannes W. J. Bijlsma, Peter Boehm, Costas A. Constantinou, Silvia Garcia-Diaz, Meliha Crnkic Kapetanovic, Kim Lauper, Mariana Luis, Jacques Morel, Gyoergy Nagy, Eva Poleverino, Jef van Rompay, Marco Sebastiani, Anja Strangfeld, Annette de Thurah, James Galloway, Kimme L. Hyrich

Summary: This study aims to develop recommendations for screening and prevention of chronic and opportunistic infections in patients with autoimmune inflammatory rheumatic diseases (AIIRD). Four overarching principles and eight specific recommendations were formulated through international collaboration. These recommendations provide guidance for clinical practice to reduce the burden of opportunistic infections in AIIRD patients.

ANNALS OF THE RHEUMATIC DISEASES (2023)

添加到收藏夹

Article Dermatology

Nonadherence to systemic immune-modifying therapy in people with psoriasis during the COVID-19 pandemic: findings from a global cross-sectional survey

Sophia Quirke-McFarlane, John Weinman, Emma S. Cook, Zenas Z. N. Yiu, Nick Dand, Sinead M. Langan, Katie Bechman, Teresa Tsakok, Kayleigh J. Mason, Helen McAteer, Freya Meynell, Bolaji Coker, Alexandra Vincent, Dominic Urmston, Amber Vesty, Jade Kelly, Camille Lancelot, Lucy Moorhead, Ines A. Barbosa, Herve Bachelez, Francesca Capon, Claudia R. Contreras, Claudia De La Cruz, Paola Di Meglio, Paolo Gisondi, Denis Jullien, Jo Lambert, Luigi Naldi, Lluis Puig, Phyllis Spuls, Tiago Torres, Richard B. Warren, Hoseah Waweru, James B. Galloway, Christopher E. M. Griffiths, Jonathan N. Barker, Sam Norton, Catherine H. Smith, Satveer K. Mahil

Summary: This study investigated the nonadherence to immune-modifying therapy in individuals with psoriasis during the COVID-19 pandemic and its association with mental health. The most common reason for nonadherence was concerns about immunity. After adjusting for potential confounders, the association between anxiety and nonadherence to immune-modifying therapy became weaker and no longer significant. This study highlights the importance of clear and adequate communication with patients during a pandemic.

BRITISH JOURNAL OF DERMATOLOGY (2023)

添加到收藏夹

Review Psychology, Clinical

The efficacy of cue exposure therapy on alcohol use disorders: A quantitative meta-analysis and systematic review

Ceyda Kiyak, Matilde E. Simonetti, Sam Norton, Paolo Deluca

Summary: This study investigated the efficacy of cue exposure therapy (CET) on alcohol use disorders (AUDs) by conducting a meta-analysis based on a previous study. The results showed that CET has small to medium effects on drinks per day, drinking days, and relapse. Future research should focus on larger scale multi-site trials with methodological innovations and improved retention.

ADDICTIVE BEHAVIORS (2023)

添加到收藏夹

Article Hematology

CAR T in patients with large B-cell lymphoma not fit for autologous transplant

A. Kuhnl, A. A. Kirkwood, C. Roddie, T. Menne, E. Tholouli, A. Bloor, C. Besley, S. Chaganti, W. Osborne, J. Norman, A. Gibb, K. Sharplin, M. Cuadrado, M. Correia de Farias, K. Cheok, L. Neill, A. L. Latif, C. Gonzalez Arias, B. Uttenthal, C. Jones, R. Johnson, A. McMillan, R. Sanderson, W. Townsend

Summary: Limited data is available on the clinical benefit of CD19 CAR T treatment in less fit large B-cell lymphoma (LBCL) patients. A real-world cohort study in the UK showed that CD19 CAR T can be safely delivered in carefully selected older patients and patients with comorbidities who are not deemed suitable for transplant, with similar response rates and survival outcomes compared to fit patients.

BRITISH JOURNAL OF HAEMATOLOGY (2023)

添加到收藏夹

Article Infectious Diseases

Rising incidence of Pneumocystis pneumonia: A population-level descriptive ecological study in England

Katharine Pates, Jimstan Periselneris, Mark D. Russell, Varun Mehra, Silke Schelenz, James B. Galloway

Summary: The incidence of Pneumocystis pneumonia (PCP) has been increasing rapidly over the past decade, posing a significant burden on the healthcare system.

JOURNAL OF INFECTION (2023)

添加到收藏夹

Article Medicine, General & Internal

Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial

Peter W. Horby, Jonathan R. Emberson, Buddha Basnyat, Mark Campbell, Leon Peto, Guilherme Pessoa-Amorim, Natalie Staplin, Raph L. Hamers, John Amuasi, Jeremy Nel, Evelyne Kestelyn, Manisha Rawal, Roshan Kumar Jha, Nguyen Thanh Phong, Uun Sumardi, Damodar Paudel, Pham Ngoc Thach, Nasronudin Nasronudin, Emma Stratton, Louise Mew, Rahuldeb Sarkar, J. Kenneth Baillie, Maya H. Buch, Jeremy Day, Saul N. Faust, Thomas Jaki, Katie Jeffery, Edmund Juszczak, Marian Knight, Wei Shen Lim, Marion Mafham, Alan Montgomery, Andrew Mumford, Kathryn Rowan, Guy Thwaites, Richard Haynes, Martin J. Landray

Summary: This study evaluated the use of high-dose corticosteroids in COVID-19 patients. The results showed that in hospitalized patients with COVID-19, high-dose corticosteroids increased the risk of death compared to low-dose corticosteroids.

LANCET (2023)

添加到收藏夹

Article Infectious Diseases

Omicron BA.1-containing mRNA-1273 boosters compared with the original COVID-19 vaccine in the UK: a randomised, observer-blind, active-controlled trial

Ivan Lee, Catherine A. Cosgrove, Patrick Moore, Claire Bethune, Rhiannon Nally, Marcin Bula, Philip A. Kalra, Rebecca Clark, Paul Dargan, Marta Boffito, Ray Sheridan, Ed Moran, Thomas C. Darton, Fiona Burns, Dinesh Saralaya, Christopher J. A. Duncan, Patrick J. Lillie, Alberto San Francisco Ramos, Eva P. Galiza, Paul Heath, Bethany Girard, Christy Parker, Dondi Rust, Shraddha Mehta, Elizabeth de Windt, Andrea Sutherland, Joanne E. Tomassini, Frank J. Dutko, Spyros Chalkias, Weiping Deng, Xing Chen, Jing Feng, Laree Tracy, Honghong Zhou, Jacqueline M. Miller, Rituparna Das

Summary: The results of this large randomized controlled trial showed that the Omicron BA.1 monovalent and bivalent boosters have superior immunogenicity against the Omicron BA.1 variant compared to the original vaccine, while having comparable immunogenicity against the original strain. Both boosters had similar safety profiles to the original vaccine.

LANCET INFECTIOUS DISEASES (2023)

添加到收藏夹

Review Radiology, Nuclear Medicine & Medical Imaging

Chimeric Antigen Receptor T-Cell Therapy and Imaging Applications for Large B-Cell Lymphoma

Nicola Mulholland, Julie Chandra, Robin Sanderson, Andrea Kuhnl

Summary: Chimeric antigen receptor (CAR) T-cell therapy has revolutionized the treatment of LBCL and other hematologic malignancies. Diagnostic imaging plays a vital role in patient selection, treatment response, and the management of adverse events. Metabolic tumor volume and kinetics assessed at PET/CT are powerful tools for outcome prediction and toxicity identification. Neuroimaging is critical in diagnosing and managing neurotoxicity. This review discusses the applications of imaging in the CAR T-cell therapy pathway for LBCL.

RADIOLOGY (2023)

添加到收藏夹

Review Oncology

The evolving use of measurable residual disease in chronic lymphocytic leukemia clinical trials

A. Fisher, H. Goradia, N. Martinez-Calle, P. E. M. Patten, T. Munir

Summary: The status of measurable residual disease (MRD) in chronic lymphocytic leukemia (CLL) is associated with improved progression-free and overall survival. MRD assessment is now included in clinical trials and used in routine practice as a prognostic tool, therapeutic goal, and trigger for early intervention. MRD provides a dynamic and robust platform for assessing CLL treatment efficacy and accelerating access to novel drugs. This article reviews recent clinical trials of CLL therapy, focusing on small-molecule inhibitors and monoclonal antibody combinations, and discusses the assessment of MRD, challenges of standardization, and the impact of MRD data on clinical decision-making.

FRONTIERS IN ONCOLOGY (2023)

添加到收藏夹

Article Psychiatry

The bidirectional effect of stress and functionality in multiple sclerosis and the interaction role of anxiety, coping and social support

Laia Briones-Buixassa, Brenda Montanes-Masias, Raimon Mila-Villaroel, Francesc X. Arrufat, Josep M. Aragones, Sam Norton, Judit Bort-Roig, Rona Moss-Morris

Summary: The present study aimed to analyze the bidirectional hypothesis between stress and multiple sclerosis, considering the interaction role of stress-related psychosocial factors. A one-year follow-up was conducted with 26 participants, and the results confirmed the bidirectional hypothesis with perceived stress and self-reported functionality. Different types of psychological therapies may benefit people with multiple sclerosis in dealing with stress and improving their quality of life.

JOURNAL OF PSYCHOSOMATIC RESEARCH (2023)

添加到收藏夹

Article Clinical Neurology

IgG4-related hypertrophic pachymeningitis with chronic subdural haematoma

Nicole Lichtblau, Jahard Aliaga-Arias, Dimitrios Kalaitzoglou, Istvan Bodi, Keyoumars Ashkan, Ranj Bhangoo, Francesco Vergani, Dorothy Joe, Biba Stanton, James Galloway, Lalani Carlton-Jones, Jose Pedro Lavrador

Summary: We report a rare case of hypertrophic pachymeningitis and bilateral chronic subdural haematoma caused by IgG4-related disease. The diagnostic challenges and possible underlying mechanisms of subdural haematoma formation in inflammatory conditions are discussed. Given the rarity and complexity of the condition, a multidisciplinary team approach is recommended for management.

PRACTICAL NEUROLOGY (2023)

添加到收藏夹

Article Surgery

Exploring Staff Attitudes Towards Unspecified Kidney Donors in the United Kingdom: Results From the BOUnD Study

Mira Zuchowski, Nizam Mamode, Heather Draper, Peter Gogalniceanu, Sam Norton, Joseph Chilcot, Timothy Auburn, Alexis Clarke, Lynsey Williams, Lisa Burnapp, Paul McCrone, Hannah Maple

Summary: This is the first in-depth qualitative study of attitudes of transplant professionals towards unspecified kidney donation (UKD). The study identified five themes: staff's conception of the ethics of UKD; presence of the known recipient in the donor-recipient dyad; need for better management of patient expectations; managing visceral reactions about the typical unspecified kidney donor; complex attitudes toward a promising new practice.

TRANSPLANT INTERNATIONAL (2023)

添加到收藏夹

暂无数据

© Peeref 2019-2024. All rights reserved.